EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia

Jinhong Nie, Lu Gao, Yingchun Shao, Li Yang, Junjie Cao, Jinge Xu, Yuhang Wang, Yuqi Zhang, Tong Cui, Shiyuan Zhou, Wenjuan Zhu, Mingqing Zhu und 3 weitere

Annals of Hematology · 02.05.2026 · 105 (5)

DOI: 10.1007/s00277-026-07010-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, online erschienen am 02.05.2026. Verfasst von Jinhong Nie und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation C…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, fms-Like Tyrosine Kinase 3, Gene Expression Regulation, Leukemic, Leukemia, Myeloid, Acute. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, Tumorfms-Like Tyrosine Kinase 3Gene Expression Regulation, LeukemicLeukemia, Myeloid, AcuteAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultMutationNucleophosminPrognosis

Stichwörter der Autor:innen

Acute myeloid leukemiaCD135 (FLT3 receptor) expressionInduction therapyNomogramOverall survival

Substanzen

Biomarkers, TumorFLT3 protein, humanfms-Like Tyrosine Kinase 3NPM1 protein, humanNucleophosmin

Autor:innen und Institutionen

  • Hematology Department, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou, China.
  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
  • Soochow Hopes Hematonosis Hospital, Suzhou, China.
  • Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
  • Department of Hematology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Nie, J., Gao, L., Shao, Y., Yang, L., Cao, J., Xu, J., Wang, Y., Zhang, Y., Cui, T., Zhou, S., Zhu, W., Zhu, M., Ma, X., Wu, D., & Wu, X. (2026). CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia. Annals of Hematology, 105(5). https://doi.org/10.1007/s00277-026-07010-3

Vancouver

Nie J, Gao L, Shao Y, Yang L, Cao J, Xu J, et al. CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia. Annals of Hematology. 2026;105(5). doi:10.1007/s00277-026-07010-3

BibTeX
@article{Nie2026,
  author = {Nie, Jinhong and Gao, Lu and Shao, Yingchun and Yang, Li and Cao, Junjie and Xu, Jinge and Wang, Yuhang and Zhang, Yuqi and Cui, Tong and Zhou, Shiyuan and Zhu, Wenjuan and Zhu, Mingqing and Ma, Xiao and Wu, Depei and Wu, Xiaojin},
  title = {CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {5},
  doi = {10.1007/s00277-026-07010-3}
}
Kostenlos starten →